Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Women with PCOS tend to be less optimistic than those without it.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.